#AI offers the ability to rapidly scale our understanding of patient experiences. Flatiron's Chief of AI and VP of Data Science, Will Shapiro, sat down with Patti Peeples, PhD to share his perspective ⬇ "New therapies are introduced regularly, new biomarkers become relevant to the standard of care, and new variables, such as social determinants of health, become crucial for the analyses researchers want to perform. The ability to dynamically update what we learn from each patient is critically important.” Read more on The Evidence Base® http://spkl.io/60484A4NI
Flatiron Health
Biotechnology Research
New York, New York 75,407 followers
Reimagining the infrastructure of cancer care
About us
Flatiron Health’s mission is to improve and extend lives by learning from the experience of every person with cancer.
- Website
-
http://www.flatiron.com
External link for Flatiron Health
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- New York, New York
- Type
- Privately Held
Locations
-
Primary
233 Spring St
5th Floor
New York, New York 10013, US
Employees at Flatiron Health
-
Elia Brandao
-
Michelle Cadrin-Msumba
Solution Design Manager // Medical Practice Management // Revenue Cycle Management // Enabling sales with data and technology // On site Needs…
-
Rahul Bafna
Healthcare Technology Product Leader
-
Mariano Peterson
Engineering Leader in Platform, Cloud, and Infrastructure
Updates
-
“The way we learn what works and to make recommendations to our patients is based on #clinicaltrials. It’s really a crisis. And it’s a societal imperative, in my opinion, to fix this problem of clinical trial representativeness.” Building off an article published in NEJM Evidence, data-driven approaches have the ability to transform #oncology trials, improve patient outcomes, and address disparities in health care. Read more in a recent interview with Neal Meropol, Head of Clinical Oncology at Flatiron Health, and The Evidence Base®. http://spkl.io/604247EtE
The role of data-driven insights in shaping inclusive cancer clinical trials: an interview with Neal Meropol, Flatiron Health
evidencebaseonline.com
-
The value of #RWD for informing better trial designs, supporting regulatory decisions, and improving patient diversity is critical as we continue to close the gap between care and research. Neal Meropol, Flatiron's Head of Research Oncology, was recently interviewed on The Bio Report with Daniel Levine to explain how #realworlddata from the EHR is transforming cancer #clinicaltrials and drug development. Tune in to learn how Flatiron Health is harnessing the power of RWD to reshape the landscape of oncology research and accelerate the development of new treatments. ▶️ https://lnkd.in/g7YvHNK3
Reshaping Clinical Trial Designs with Real-World Data | The Bio Report
thebioreport.podbean.com
-
After another incredible #ASCO24, Neal Meropol shared his thoughts on themes that emerged, their relevance to Flatiron Health, and their impact on the future of cancer care. Click below to read more ⬇️ http://spkl.io/60474A4FD
-
Scientific advancements have occurred across almost every realm of #breastcancer in the last three decades, including the discovery of novel biomarkers, the development and approval of novel therapies, and our understanding of the disease. Join a panel of experts from across the industry, including #clinicalresearch, drug commercialization, and clinical practice, for the current state of breast cancer research today and where it’s headed ⬇️ ⭐Bridging Innovation and Practice: The Current and Future Landscape of Breast Cancer Care 🗣️Neelima Denduluri MD, FASCO, AstraZeneca; Angela DeMichele MD, MSCE, FASCO, University of Pennsylvania School of Medicine; iuliana shapira, Regional Cancer Care Associates; and moderated by Emily Castellanos , Flatiron Health 📅Tuesday, July 23rd 12-1 PM ET Secure your spot & ask our panel of experts your questions directly. Register & submit questions now: http://spkl.io/60414ALB5
Bridging Innovation and Practice: The Current and Future Landscape of Breast Cancer Care
page.flatiron.com
-
Flatiron Health’s VP Strategic Partnerships and Alliances, Nina Chavez, shares how our newly launched Trusted Partner Network helps partners expand their reach and drive greater value for community oncology. Read more to learn about how we continue to innovate and help our customers access the solutions they need to thrive. https://lnkd.in/eY_63UiW
Empowering Community Oncology: Flatiron Health's Trusted Partner Network
resources.flatiron.com
-
June is #PrideMonth, a time for celebrating the LGBTQIA+ community, a time for the community to celebrate themselves, a time to remember the long strides that have been taken toward equality, and a time to stand together in solidarity as we look forward to the opportunity, progress, and positivity that still lies ahead. At Flatiron, our LGBTQIA+ Employee Resource Group (ERG), Velvet Mafia, creates a safe space for ERG members and allies alike to learn about LGBTQIA+ history, share stories of acceptance, and support one another. This year, Velvet Mafia is celebrating the month in numerous ways, including a variety of hybrid and in person events like the annual remote-friendly Queer Trivia and a Pride Karaoke Party, as well as their annual T-shirt Fundraiser in which all proceeds will go to Zebra Youth. Scroll through to see photos of Flatiron employees joining in on the celebration! 🏳️🌈
-
+3
-
At Flatiron Health we aim to drive change in the world of cancer care and research. Apply today to be a part of our community of changemakers. https://bit.ly/3ONI8pC
-
"People coming into the workforce post-COVID are probably a lot less experienced…so the need to continuously work on upskilling our workforce has become really very important." As the 2023-2024 President of Association of Cancer Care Centers, Olalekan Ajayi PharmD MBA FACCC, sees firsthand the need to upskill the oncology workforce in our post-pandemic reality. Ajayi is focused on leveraging technology and leadership to better prepare staff for the complexities of modern cancer care delivery. This is where Flatiron's long standing partnership with ACCC becomes invaluable. Listen to the ACCC President-elect discuss how partners like Flatiron are enabling smarter, more supported cancer care through technology. http://spkl.io/60434AkMJ
COA insights: Leveraging technology for smarter cancer care delivery
resources.flatiron.com
-
After another successful American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Meropol shares his thoughts on themes that emerged, their relevance to Flatiron Health, and their impact on the future of cancer care. Click below to read more ⬇️ https://lnkd.in/e_UnRDEa
ASCO 2024 Reflections and Highlights
resources.flatiron.com